Strategy& Insider cover art

Strategy& Insider

Strategy& Insider

By: Thomas Solbach Ghioia Irritier Jan-Philipp Loch
Listen for free

The Strategy& Insider podcast aims to explore some of the most critical future trends and their impacts. Strategy& talks to industry experts and leading practitioners from different sectors. The conversations will make you more familiar with key developments by providing you with insights that really matter. The first season will tackle some of the most fundamental questions in the healthcare industry. While technology has quickly transformed how we shop, bank, and travel, it yet has to impact on how we receive healthcare. The adoption of digitally enabled tools for diagnostics, treatment, and management, for example, has been rather modest - especially compared to what is already possible. Together with experts across all sectors including pharma executives, leading academics and practitioners at hospitals we will discuss how the healthcare industry is expected to change.PwC Strategy& (Germany) GmbH Economics Hygiene & Healthy Living Management Management & Leadership Physical Illness & Disease
Episodes
  • Strategy& Insider Episode 46 - Detecting disease in seconds of speech
    May 20 2026
    Lara Gervaise and Edoardo Giudice are the co-founders of Virtuosis AI, a start-up pioneering voice biomarker technology. In this episode, they reveal how just 30 seconds of speech can be analyzed to screen for up to 25 health conditions – from Parkinson's and Alzheimer's to depression, anxiety, and cardiometabolic disorders. They share how a chance meeting before generative AI even existed sparked a conviction that voice and AI could transform preventive care at scale. The conversation covers their path from wellness tool to CE-certified medical device, the ethical safeguards behind their workplace integration, what it takes to build health AI in Europe's regulatory environment, and their ultimate vision: a future where monitoring your voice is as routine as tracking your steps, seamlessly embedded into everyday life.
    Show More Show Less
    47 mins
  • Strategy& Insider Episode 45 - Matching patients with the right medical specialists
    Apr 15 2026
    Nils von Dellingshausen is the CEO and co-founder of BetterDoc, a digital platform transforming how patients find the right doctor for their specific conditions. In this episode, he shares how his company uses proprietary data, expert physician panels, and a rigorous matching methodology to cut through misleading healthcare information and connect patients with their custom-fit medical specialists. He discusses the cultural barriers around second opinions, the critical line between AI-assisted information processing and human medical judgment, and his vision for indication-specific care pathways that follow patients throughout their entire healthcare journey. Tune in for an insightful conversation on patient empowerment, data-driven transparency, and the future of healthcare navigation.
    Show More Show Less
    48 mins
  • Strategy& Insider Episode 44 - Expanding access to essential medicines
    Mar 19 2026
    What does it take to get a life-changing medicine from regulatory approval to the patient who needs it? Isabell Remus, Global Head of Biosimilars at Sandoz, reveals why being approved and affordable isn't enough – and how the biosimilar industry learned that trust and education must come before market access. With $320 billion in biologic medicines losing patent exclusivity over the next decade, she explores the strategic complexities of launching at the exact moment a patent expires, the role of diversified manufacturing in strengthening supply chain resilience, and why expanding access to essential medications requires both purpose and commercial viability. An eye-opening conversation on making affordable healthcare a reality for millions of patients worldwide.
    Show More Show Less
    37 mins
adbl_web_anon_alc_button_suppression_c
No reviews yet